Nestle USA Inc. — Hazelnut Sugar Free Coffee Creamer, Hazelnut
by Nestle USA Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Nestle USA Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 5 MRT-tested substances. Corn is present through corn syrup and maltodextrin. The vegetable oil component contains both Soybean and Canola/Rapeseed. Micellar casein is a protein derivative of Cow’s Milk. Carrageenan is included as a chemical stabilizer. Additionally, ‘natural flavors’ represents an unknown source of potential triggers. Due to the high trigger count, this product is unsuitable for Phase 1 (Elimination) and should only be considered in Phase 3 under practitioner guidance. This is procedural data interpretation, not medical guidance.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 5
- Safe Ingredients: 4
- Unknown/Ambiguous: 1 (natural and artificial flavor)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel. Each ingredient is mapped to its corresponding panel analyte:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| corn syrup | Corn | Direct Match |
| soybean oil | Soybean | Direct Match |
| canola oil | Canola/Rapeseed | Direct Match |
| micellar casein | Cow’s Milk | Derivative Match |
| maltodextrin | Corn | Derivative Match |
| carrageenan | Carrageenan | Chemical Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel and may contain hidden triggers: natural and artificial flavor. Patients should treat these as potential triggers until MRT testing confirms safety. Common examples include ‘natural flavors’ (which can contain any of the 176 tested substances) and ‘spices’ (which may include tested spices like cinnamon, cumin, or black pepper).
LEAP Protocol Guidance
With 5 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2 of the LEAP protocol. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist for personalized evaluation based on their individual MRT results.
UPC Code: 050000848089
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient in the product was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives. Ingredient-to-panel mapping uses direct matching, derivative identification (e.g., ‘whey’ maps to Cow’s Milk), and chemical compound recognition. Hidden trigger sources such as ‘natural flavors’ and ‘spices’ are flagged as unknown variables requiring individual verification.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Corn derivatives are among the hardest triggers to avoid. Found as corn syrup, cornstarch, modified food starch, dextrose, maltodextrin, and citric acid in thousands of processed products.
Soy-derived ingredients appear in a wide range of processed foods including soy lecithin, soybean oil, and textured soy protein. One of the most prevalent hidden triggers.
Canola oil (derived from rapeseed) is an MRT-tested substance. It is one of the most common cooking oils in processed foods and restaurant cooking. Look for it in fried foods, dressings, and baked goods.
One of the most commonly reactive substances on the MRT panel. Found in dairy products and many processed foods as whey, casein, or milk solids. Cross-reactive with goat and sheep milk in some patients.
A seaweed-derived thickener tested on the MRT panel. Found in dairy alternatives, ice cream, deli meats, and protein shakes. Increasingly scrutinized for its inflammatory potential.
What This Means For Your Diet
With 5 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 5 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from Nestle USA Inc.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners